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Background: Evidence from patients and animal models suggests that obstructive 
sleep apnea (OSA) may increase the risk of Alzheimer’s disease (AD) and that AD is 
associated with reduced brain tissue stiffness.
aim: To investigate whether intermittent hypoxia (IH) alters brain cortex tissue stiffness in 
AD mutant mice exposed to IH mimicking OSA.
Methods: Six-eight month old (B6C3-Tg(APPswe,PSEN1dE9)85Dbo/J) AD mutant 
mice and wild-type (WT) littermates were subjected to IH (21% O2 40 s to 5% O2 20 s; 
6 h/day) or normoxia for 8 weeks. After euthanasia, the stiffness (E) of 200-μm brain 
cortex slices was measured by atomic force microscopy.
results: Two-way ANOVA indicated significant cortical softening and weight increase in 
AD mice compared to WT littermates, but no significant effects of IH on cortical stiffness 
and weight were detected. In addition, reduced myelin was apparent in AD (vs. WT), but 
no significant differences emerged in the cortex extracellular matrix components laminin 
and glycosaminoglycans when comparing baseline AD and WT mice.
conclusion: AD mutant mice exhibit reduced brain tissue stiffness following both 
normoxia and IH mimicking sleep apnea, and such differences are commensurate with 
increased edema and demyelination in AD.
Keywords: atomic force microscopy, brain mechanics, cortex stiffness, neurodegenerative disease, animal model
inTrODUcTiOn
Chronic intermittent hypoxia (IH), sleep fragmentation, and increased intrathoracic negative pres-
sure swings are hallmark deleterious perturbations experienced by patients with obstructive sleep 
apnea (OSA). The oxidative stress and local and systemic inflammation elicited by the nocturnal 
cycles of hypoxia-reoxygenation experienced by patients with OSA (1, 2) are considered among 
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the primary mechanisms triggering both the mid-term and the 
long-term adverse consequences of this sleep breathing disorder, 
namely increased risk of cardiovascular, metabolic, malignant, 
and neurocognitive diseases (3–7).
The prevalence of OSA, which is already considerable nowa-
days (8), is further anticipated to increase in the near future for 
the following reasons: (i) as a result of the current epidemic 
of obesity [one of the main risk factors for OSA (9)] in both 
developed and developing countries and (ii) aging of the popula-
tion in light of the fact that OSA prevalence increases with age 
(8). Furthermore, population aging has potentially important 
implications for public health, since it has been suggested that 
OSA could boost the progression of Alzheimer’s disease (AD), 
one of the most relevant neurocognitive degenerative disorders 
associated with the aging process (10, 11). It has been proposed 
that the association between OSA and AD stems from the fact 
that both oxidative stress and inflammation are induced by OSA 
and enhance AD-related pathways (12–18). The existence of such 
an OSA-AD interdependence is supported by experimental data 
reporting that chronic IH boosts the expression of AD biomark-
ers and has negative neurocognitive impact in rodents (19), and 
by epidemiological studies showing a robust association between 
AD and OSA in humans (20, 21).
Intensive research efforts are currently ongoing aimed at 
implementing simple methods for early detection and long-term 
tracking of AD progression. In this context, one approach that has 
been recently proposed for this purpose is magnetic resonance 
elastography (MRE). This technique allows the noninvasive 
estimation of tissue stiffness in internal organs (22–24), and 
preliminary data indicates that AD is accompanied by reduced 
cerebral tissue stiffness in both animal models and patients 
(25–27). Accordingly, it has been proposed that brain tissue 
stiffness measured by MRE could be a mechanical biomarker for 
routine assessments of AD. Based on aforementioned considera-
tions, we have recently found that IH exposures simulating OSA 
do not modify brain stiffness characteristics in healthy mice (28). 
However, whether an IH challenge affects the stiffness of brains 
with underlying ongoing AD-related processes—a most relevant 
question from the translational viewpoint—is still open. To 
further our understanding on the potential relationship between 
OSA and AD, the aim of the present study was to investigate 
whether chronic IH changes the mechanical properties of brain 
cortex in a well characterized mutant mouse model of AD. To this 
effect, we used atomic force microscopy (AFM) to directly and 
precisely measure the local Young’s modulus of brain cortex and 
investigated potential mechanisms that may account for some of 
the brain mechanical changes observed in these animals.
MaTerials anD MeThODs
animals
Alzheimer’s disease model mice (ADm; N  =  16) of strain 
B6C3-Tg(APPswe,PSEN1dE9)85Dbo/J and their wild-type 
(WT; N = 27) littermates (all animals genotyped at the time of 
weaning) were used for the study. All mice (6–8  months old) 
were conventionally housed with water and food ad libitum and 
kept at 25°C under light-control (12L:12D). The experimental 
procedures were approved by the Ethics Committee of Animal 
Experimentation of the University of Barcelona following the 
local and European regulations in force.
application of chronic ih
At the beginning of the experimental procedures, mice were ran-
domly distributed into four groups: two groups for IH exposures 
(17 WT and 8 ADm mice) and two groups for normoxic room air 
(RA) (10 WT and 8 ADm mice). To apply IH, mice were placed 
in ~3 l boxes (26 cm long, 18 cm wide, 6 cm high) flushed with 
air with cyclic changes in oxygen content (40  s of RA at 21% 
O2 and 20 s of hypoxic air at 2% O2) with a rate of 60 events/h 
mimicking severe OSA. A zirconia solid-electrolyte cell oxygen 
sensor (MWL-F, 0.1–95% O2 ± 1%, Fujikura Ltd., Tokyo, Japan) 
was connected to the gas outlet of the box to continually measure 
the FiO2 in the chamber, showing that the air breathed by the 
mice ranged 21–5% O2. IH was applied for 6 h/day during the 
light period (10:00–16:00) for 8 weeks, with food and water freely 
available, as previously described (29). The mice subjected to RA 
were placed in similar boxes continuously flushed with normoxic 
air instead of hypoxic gas.
Brain Tissue sample Preparation
Mice were anesthetized with isoflurane and euthanized by cervi-
cal dislocation. Whole brains were extracted and weighted. For 
each brain the right and the left hemispheres were separated. 
From the right hemispheres, the cortices were isolated, weighted, 
and were then OCT-embedded. The left hemispheres were placed 
in ice-cold Krebs–Henseleit buffer modified and 200-µm thick 
coronal slices (between Bregma −1 mm and Bregma −2.5 mm) 
were obtained using a vibratome, and kept in ice-cold Krebs-
Henseleit buffer until AFM measurements. The remaining tissue 
was fixed overnight with 4% PFA and paraffin embedded. All 
samples were code-labeled in a way that the operators involved 
in all the subsequent experimental processes were blinded to the 
sample group.
Measurement of Brain cortical stiffness 
by aFM
The local stiffness of brain cortex was measured by AFM using 
a protocol described elsewhere (28). For each mouse, one brain 
slice was placed on the sample holder of a custom-built AFM 
mounted on an inverted optical microscope (TE2000; Nikon) 
within a 37°C-controlled environment. The slice was secured 
on the substrate inside a Petri dish by means of soft mesh of 
silicone thread (0.25 mm in diameter, 2 mm-spaced) in a ring. 
Then, dorsal cortical stiffness was measured in 9 points at the 
somatosensory area of the gray matter randomly selected and 
separated ~50–100 μm form each other. All measurements in each 
mouse were performed within 45  min after mouse euthanasia. 
A V-shaped Au-coated silicon nitride cantilever (0.01 N/m nomi-
nal stiffness) ended with a 12.5 µm radius spherical polystyrene 
bead (Novascan Technologies, Ames, IA, USA) was calibrated 
by the conventional thermal tune oscillation before cortical 
measurements. The piezoactuator-controlled vertical position of 
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the cantilever (z) was measured with strain gage sensors (Physik 
Instrumente, Karlsruhe, Germany) and a quadrant photodiode 
(S4349, Hamamatsu, Japan) was employed to measure cantilever 
deflection (d). The relationship between the cantilever deflection 
and the photodiode signal was determined from a deflection– 
displacement d–z curve obtained in a bare region of the coverslip. 
The force (F) on the cantilever was determined as F = k·(d − d0), 
with k being the cantilever spring constant. The indentation 
magnitude δ was defined as δ = (z − z0) − (d − d0), with d0 and z0 
being the offset of deflection and the displacement of the cantile-
ver when the tip contacts the surface of the sample, respectively. 
The Hertz contact model for a sphere indenting a semi-infinite 
half space was employed: F E
v
R=
−( )
4
3 1 2
1
2
3
2δ , with R = 12.5 μm 
being the radius of the bead, v = 0.5 the Poisson’s ratio and E the 
Young’s modulus. Using the previous equations for each force-
indentation curve, E, z0 and d0 were determined by least-squares 
fitting considering maximum indentation values of ~1.5 μm. E for 
each measured point was computed as the average of the values 
obtained from 5 F-z curves (10 µm of ramp amplitude and 0.5 Hz 
of frequency; tip velocity of 10 µm/s).
Visualization of the Brain amyloid Plaque 
Deposition
Paraffin-embedded brain sections of 5 µm thickness were used to 
determine the presence of amyloid-β positive plaques. The tissue 
sections were deparaffinized, hydrated and incubated with 90% 
formic acid for 7 min at room temperature as antigen retrieval. To 
avoid unspecific binding, the slices then were blocked with 10% 
goat serum for 30 min at room temperature and incubated with 
the primary antibody solution overnight at 4°C. Mouse anti-β-
amyloid clone 4G8 (800701, BioLegend) diluted 1:100 was used 
as primary antibody. Finally, the slices were incubated with goat 
anti-mouse-Alexa 488 (111-545-146, Jackson ImmunoResearch) 
as secondary antibody during 45 min at room temperature and 
mounted with Fluoromount-G (0100-01, SouthernBiotech). 
Nuclei were stained with NucBlue (R37605, ThermoFisher 
Scientific). Large epifluorescence images (10 images × 10 images) 
were obtained from each slice with the Nikon ECLIPSE Ti.
assessment of glycosaminoglicans 
(gags) in Brain cortex
Cortical frozen slices (20-µm thick) were stained with Alcian Blue 
to determine GAGs content. The cryosections were incubated over-
night at room temperature with Alcian Blue solution [0.05% Alcian 
Blue 8GX (A3157, Sigma), 0.05 M sodium acetate and 0.1 M MgCl2 
at pH =  5.7]. Subsequently, the slices were washed in  deionized 
water, dehydrated by two changes of 95% ethanol and absolute 
ethanol (5  min each), and mounted with DPX (44581, Sigma). 
Color images of the cortex were obtained using optical microscopy 
(ZEISS Axiovert S100) and were analyzed with ImageJ software to 
compute the number of pixels of GAGs staining per μm2.
assessment of laminin in Brain cortex
Cortical frozen slices (20-µm thick) were used to assess laminin. 
Cryosections were defrost and permeabilized with 70% ice-cold 
methanol and 30% acetone for 5  min at room temperature 
and blocked with 10% fetal bovine serum for 30  min at room 
temperature to avoid unspecific binding and were incubated 
with the primary antibody solution overnight at 4°C. Rabbit 
anti-laminin (L9393, Sigma) diluted 1:200 was used as primary 
antibody. Finally, the slices were incubated with goat anti-rabbit-
Alexa 488 (111-545-003, Jackson ImmunoResearch) as secondary 
anti body for 45  min at room temperature and mounted with 
Fluoromount-G (0100-01, SouthernBiotech). Nuclei were stained 
with NucBlue (R37605, ThermoFisher Scientific). Epifluorescence 
images from each cortical slice were obtained (Nikon ECLIPSE 
Ti) and analyzed with ImageJ software to compute the number of 
laminin-stained pixels per μm2.
assessment of Myelin content in the Brain 
cortex
Five-micron thick paraffin-embedded brain sections were stained 
with Luxol Fast Blue Stain (ab150675, Abcam) to assess their 
myelin content. The sections were deparaffinized, hydrated and 
incubated with Luxol Fast Blue Solution for 24 h at room tempera-
ture and subsequently rinsed in deionized water and differentiated 
in Lithium Carbonate followed by Alcohol Reagent. Finally, the 
slices were counterstained with Cresyl Echt Violet, dehydrated in 
absolute ethanol, and mounted with DPX. Color images along cor-
pus callosum of each slice were obtained using optical microscopy 
(ZEISS Axiovert S100) and were analyzed with ImageJ software. 
To quantify the stained areas, the cyan color of each image was 
selected by using the Colour Deconvolution plugin of ImageJ 
software with the vector FastRed FastBlue DAB. The threshold 
intensity was manually set and kept constant in order to subtract 
the background of the staining and the Luxol Fast Blue positive 
pixels were determined to compute fold change in myelin content 
as described previously (30). All image analyses were performed 
by a single examiner who was blinded to sample group.
statistical analysis
All values are expressed as mean ± SE. Two-way ANOVA were 
used to compare changes in cortical weight, brain weight, and 
E owing to treatment (IH vs. normoxia) and genotype (WT vs. 
ADm). F-values (F) and degrees of freedom (DF) from each vari-
able are also provided. Student’s t-test was employed to compare 
histological staining between WT and ADm groups. Statistical 
significance was considered when p < 0.05.
resUlTs
As expected from genotyping, amyloid-β positive plaques were 
observed in the cortex of all ADm mice and in none of the WT 
littermates, as illustrated by the examples shown in Figure 1.
No significant differences were observed in total brain weights 
for each factor (IH vs. normoxia; DF = 1, F = 2.654, p = 0.111 
and WT vs. ADm; DF =  1, F =  0.0992, p =  0.754). However, 
cortex weight was significantly higher in ADm (98.3 ± 2.5 and 
93.1 ± 2.5 mg in RA and IH, respectively) when compared with 
WT (91.6 ± 1.9 and 89.6 ± 1.6 mg in RA and IH, respectively) 
mice (DF = 1, F = 6.042, p = 0.019). No significant differences 
FigUre 3 | Stiffness of the cortex. The Young’s modulus (E) is a direct 
measurement of local tissue stiffness showing that cortical tissue was softer 
in ADm mice than in WT mice. E values from the four experimental groups, 
WT mice subjected to RA (black bar) and IH (dashed black bar) and ADm 
mice subjected to RA (red bar) and IH (dashed red bar). Cortical tissue 
stiffness was significantly lower in ADm mice vs. WT littermate controls 
(DF = 1, F = 6.198, p = 0.017). Two-way ANOVA, *p < 0.05. Data are 
presented as mean ± SE. WT, wild type; RA, room air; IH, intermittent 
hypoxia; ADm, Alzheimer’s disease transgenic mouse.
FigUre 2 | Cerebral and cortical weights. (a) Whole brain weights from the 
four experimental groups: WT mice subjected to RA (black bar) and IH 
(dashed black bar) and ADm mice subjected to RA (red bar) and IH (dashed 
red bar). Two-way ANOVA revealed no differences between experimental 
groups (IH vs. normoxia; DF = 1, F = 2.654, p = 0.111 and WT vs. ADm; 
DF = 1, F = 0.0992, p = 0.754). (B) Cortical weights from all the four 
experimental groups: WT mice subjected to RA (black bar) and IH (dashed 
black bar) and ADm mice subjected to RA (red bar) and IH (dashed red bar). 
Cortical weight was significantly higher in ADm mice compared to littermate 
controls (WT) (DF = 1, F = 6.042, p = 0.019). Two-way ANOVA analysis, 
*p < 0.05. Data are presented as mean ± SE. WT, wild type; RA, room air; 
IH, intermittent hypoxia; ADm, Alzheimer’s disease transgenic mouse.
FigUre 1 | Illustrative example of amyloid-β positive plaque deposition. 
Coronal sections of paraffin-embedded brains from WT (a) and ADm  
(B) mice were stained using clone 4G8 immunosera. White arrowheads 
highlight the positive amyloid-β plaques deposited throughout the brain in 
ADm mice. Scale bar 500 µm. WT, wild type; ADm, Alzheimer’s disease 
transgenic mouse.
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in brain and cortex weights emerged in IH-exposed mice when 
compared with the corresponding normoxic controls (DF =  1, 
F = 2.959, p = 0.094) (Figure 2). There was no statistically signifi-
cant interaction between genotype (WT vs. ADm) and treatment 
(IH vs. normoxia) neither for brain (p =  0.618) nor for cortex 
weight (p = 0.449).
Figure 3 depicts the Young’s modulus (E) of the cortex which 
is a direct measurement of local tissue stiffness. This figure shows 
that genotype was a factor significantly modifying the local stiff-
ness of brain cortex (ADm softer than WT) (DF = 1, F = 6.198, 
p = 0.017), which was not significantly altered by IH-exposures 
(DF = 1, F = 0.246, p = 0.623). In normoxia, E (mean ± SE; in Pa) 
was 402 ± 97 and 651 ± 138 in ADm and WT, respectively. After 
the IH exposures, E (in Pa) was 316 ± 78 and 637 ± 115 in ADm 
and WT, respectively. The ANOVA analysis revealed that there 
was no statistically significant interaction between genotype and 
treatment factor (p = 0.656).
No differences between ADm and WT emerged in the 
two most abundant extracellular cortical components, GAGs 
(Figure 4) and laminin (Figure 5). In contrast, ADm mice showed 
significantly less myelin content than WT littermates (Figure 6). 
Analysis of GAGs, laminin and myelin was carried out only in 
normoxic mice (five ADm and five WT) since IH did not modify 
cortical stiffness.
DiscUssiOn
The emerging clinical interest of evaluating brain mechanical 
properties such as stiffness as a potential marker of AD, along 
with the cumulative evidence linking to mutually deleterious 
interactions between AD and OSA prompted the current study. 
Here, we focused on investigating whether application of chronic 
IH mimicking this sleep-disordered breathing adversely impacted 
on brain stiffness characteristics. Our findings showed that the 
brain cortex of ADm mice is considerably softer than their WT 
littermates, and that application of IH mimicking severe OSA did 
FigUre 4 | Cortical glycosaminoglicans (GAGs) staining. Cortical 
cryosections from WT mice (a) and ADm mice (B) subjected to RA 
exposures were stained with Alcian Blue. Scale bar 250 µm. (c) 
Quantification of the blue pixels (GAGs) per area (μm2) in WT tissue (black 
bar) and in ADm tissue (red bar) using Image J software. Using t-test 
analysis, no statistical differences between the two groups, WT vs. ADm, 
were found. Data are presented as mean ± SE. WT, wild type; ADm, 
Alzheimer’s disease transgenic mouse; RA, room air.
FigUre 5 | Cortical laminin staining. Cortical cryosections from WT mice (a) 
and ADm mice (B) subjected to RA exposures were stained with anti-laminin 
antibody. Scale bar 200 µm. (c) Quantification of the green pixels (laminin) 
per area (μm2) in WT tissue (black bar) and in ADm tissue (red bar) using 
Image J software. Using t-test analysis no statistical differences between the 
two groups, WT vs. ADm, were found. Data are presented as mean ± SE. 
WT, wild type; ADm, Alzheimer’s disease transgenic mouse; RA, room air.
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not modify cortical stiffness. The different stiffness found in ADm 
and WT mice is unlikely attributable to changes in extracellular 
matrix (ECM) components (laminin and GAGs) and is more 
likely accounted for the presence of edema, assessed by increases 
in cortex weight, as well as by demyelination. Thus, increases in 
overall water content and decreases in myelin emerge as potential 
mechanisms explaining the different mechanical properties of 
AD brains.
This study was performed by combining two conventional 
experimental models mimicking AD and OSA, respectively. 
First, a well-characterized mutant mouse strain of AD was 
employed. Among the several AD mouse models available 
(31, 32), we selected the B6C3-Tg(APPswe,PSEN1dE9)85Dbo/J 
mouse model—more commonly known as APP/PS1. This double 
transgenic mouse expresses a chimeric mouse/human amyloid 
precursor protein (Mo/HuAPP695swe) and a mutant human 
presenilin 1 (PS1-dE9), which are both directed to central nerv-
ous system neurons. Both of these mutations are associated with 
early-onset AD. In fact, this animal model is characterized by 
deposition of brain amyloid plaques (Figure 1) and with detect-
able and explicit neurocognitive alterations at the age of the mice 
used in this study (6–8  months) (33–35). Second, the model 
employed to mimic OSA was IH. The IH paradigm employed in 
this work (20% O2 40 s to 6% O2 20 s; 6 h/day; 8 weeks) simulates 
the hypoxia-reoxygenation events experienced by patients with 
considerably severe OSA readily reproducing the local and 
systemic effects observed in these patients. The model induces 
oxidative stress and inflammation, and augments metabolic, 
neurocognitive, cardiovascular and cancer consequences (1–3). 
In the brain, the IH exposures induce local events of hypoxia/
reoxygenation (36, 37), promote activation and propagation 
of inflammatory and oxidative stress cascades (38–40), and 
lead to hypomyelination (41) and neuronal apoptosis (42–44), 
thereby resulting in neurocognitive and behavioral alterations 
(41, 45, 46). Importantly in the context of this study on AD, IH 
significantly increased the generation of β-amyloid peptides in 
3xTgAD mutant mice harboring PS1M146V, APPSwe and tauP301L 
transgenes (19).
Here, we employed AFM to measure brain mechanical 
properties, since this technique allows us to directly measure the 
absolute value of the Young’s modulus (E) at well-defined sites in 
brain samples (47). Moreover, particular attention was paid to 
reduce the potential sources of experimental variability. To mini-
mize the temperature dependence of measured stiffness (48), the 
brain tissues were kept in cold medium immediately after animal 
sacrifice, and also throughout the duration of the experimental 
processing of the samples, including manipulation and slicing. 
Moreover, cortex stiffness measurements were performed within 
a short time after euthanasia (49). The precision and resolution of 
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FigUre 6 | Myelin staining. Coronal sections of paraffin-embedded brains 
from WT mice (a) and ADm mice (B) exposed to RA were stained with Luxol 
Fast Blue. Scale bar 250 µm. (c) Quantification of the Luxol Fast Blue fold 
change (myelin) in WT tissue (black bar) and in ADm tissue (red bar) using 
Image J software. ADm mice showed a statistical significant decrease in the 
levels of brain myelin compared to the control mice, WT. t-Test, **p < 0.01. 
Data are presented as mean ± SE. WT, wild type; ADm, Alzheimer’s disease 
transgenic mouse; RA, room air.
AFM contrast with those provided by MRE. MRE is non-invasive 
and is based on image acquisition and processing using inversion 
model-based algorithms to derive a stiffness map of the organ 
(22–24). Not surprisingly, this complex process is associated 
with potential uncertainty (24, 50). In this context, the results 
obtained in the present study provide validation of MRE. Indeed, 
the precisely measured stiffness in this study shows reduced stiff-
ness in ADm brains, thereby confirming the scarce previous data 
indirectly measured by non-invasive MRE in both AD animal 
models (25) and patients (26, 27). Of note, it is remarkable that 
the cortex stiffness reductions in ADm mice measured herein by 
AFM (21 and 38% in IH and RA, respectively) are quite consistent 
with the 22.5% reductions in brain stiffness previously measured 
by MRE in the same AD mutant mouse strain (25). Therefore, 
although it was not an aim of this study, the present results are of 
interest for clinical translation, since they provide strong support 
to the capability of MRE for detecting tissue changes in altered 
brains (51, 52).
The results in the present animal model work indicate that 
exposures to severe IH, eliciting oxidative stress and inflamma-
tion, do not modify the underlying alterations of cortical brain 
stiffness induced by AD. Given that the few previous studies avail-
able on brain mechanics in AD were observational (25–27), in the 
present work, we investigated potential mechanisms explaining 
brain softening in AD. In most body tissues, stiffness is mainly 
determined by its ECM, with elastin and collagen being the key 
components providing mechanical support. However, these two 
structural molecular species are almost absent in the brain, with 
laminin and GAGs accounting for the main ECM components 
(53). The fact that the abundance of both laminin and GAGs was 
not different in ADm and WT mice (Figures 4 and 5) suggests 
that the differences observed in cortical stiffness were not caused 
by AD-induced alterations in the tissue ECM. However, although 
not far from providing a definitive proof, the results reported in 
Figures 2 and 6 give clues to potentially explain brain tissue sof-
tening in AD. Indeed, the significant increase in cortical weight 
in ADm mice is suggestive of edema, which in fact has been 
reported in the AD brain (54, 55). In this context, increases in 
the proportion of water in the tissue are expected to reduce tissue 
stiffness (56). Moreover, the demyelination observed here in the 
ADm brains, which is characteristic in this disease (57, 58), is 
expected to further reduce tissue stiffness, particularly in light 
of the inverse relationship between brain stiffness and myelin 
content (59, 60).
cOnclUsiOn
Chronic IH, a hallmark feature of OSA that characteristically 
induces oxidative stress and inflammation, does not modify the 
stiffness of brain cortex in normal mice, and similarly does not 
alter the mechanical properties of the cortex in a murine model 
of early-onset AD. Moreover, precise measurements of brain stiff-
ness by AFM are supportive of previous evidence suggesting that 
MRE is a potentially valid and useful non-invasive mechanical 
marker of AD. The softening observed in AD mouse brain is likely 
attributable to edema and demyelination, although more research 
is required to better understand how AD and OSA modify brain 
mechanics.
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